Skip to main content
LIFE logo

LIFE · Ethos Technologies Inc.

Track LIFE — free
$33.26 -0.26 (-0.78%) At close · Nov 13
Market Cap
$2.16B
Shares
65.02M
Volume · Nov 13 1.12M Avg daily vol (3M) 1.59M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$33.26 Open$33.61 Day$33.00–34.23 Available close range$9.85–44.22 Avg vol 30d1.6M Short int3.7M · 5.7% of shares · 2.9d Short vol36% Last earningsNov 2, 2026 DataJan 2026–Nov 2026 Filing10-Q · Nov 4

The closing range uses available history since Jan 29, 2026; less than a full year is stored.

Up next

Feb 24, 2027 Est · unconfirmed · in 14 wks

Latest documents

2026
Nov 4
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Quarterly report for FY2026 Q3 AI summary on its way
Revenue $235.22M ▲ 150.8% Net income $4.67M ▼ 70.6% Diluted EPS $0.07 ▼ 74.1%
Nov 2
Earnings call
Q3 2026 earnings call

Ethos reported third-quarter revenue of $235 million, up 151% year-over-year, and adjusted EBITDA of $35 million. It raised full-year 2026 revenue guidance to $838 to $842 million and adjusted EBITDA guidance to $134 to $136 million.

Nov 2
Current report 8-K
Financial results

Ethos reported Q3 revenue of $235.2 million, up 151% year-over-year, net income of $4.7 million and Adjusted EBITDA of $34.9 million. It authorized a $100 million share repurchase and forecast fiscal 2026 revenue of $838 million to $842 million.

Oct 9
Current report 8-K Events of Sep 30
Other events

As of September 30, 2026, Ethos Technologies Inc. updated beneficial ownership information for the December 2026 Russell indices reconstitution. Its executive officers and directors collectively owned 1,195,733 Class A shares and 17,341,174 Class B shares, representing 68.6% of voting power.

All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$727.95M
Trailing 12 months
Net income (TTM)
−$117.63M
Trailing 12 months
Revenue growth YoY
+150.8%
Year over year
Operating margin
-16.1%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
5.1%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$221.46M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+18.9%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
5.7%
Latest settlement · 2.9 days to cover
View all 125 metrics

AI Brief

Q2 FY26 earnings call · Aug 3, 2026
Q2 FY26

TL;DR. Ethos reported Q2 revenue of $189.6 million, up 113% year-over-year, with adjusted EBITDA of $35.2 million, and raised its full-year 2026 revenue outlook to $727–$731 million and adjusted EBITDA to $119–$123 million. The Board also authorized a $100 million share repurchase program.

Bullish
  • + Q2 revenue grew 113% year-over-year to $189.6 million, a second consecutive quarter above 100%
  • + Direct channel revenue grew 131% year-over-year to $116.5 million
  • + Third-party channel revenue grew 90% year-over-year to $73.1 million, a second consecutive quarter of acceleration
  • + Raised full-year 2026 revenue guidance to $727–$731 million (88% growth at midpoint) and adjusted EBITDA to $119–$123 million
  • + Activated 107,847 new policies, bringing protected families above 700,000 cumulative
  • + Board authorized a $100 million Class A share repurchase program
Bearish
  • − Contribution margin compressed to 33% from 42% a year ago on channel and product mix
  • − Average revenue per policy fell 8% year-over-year to $1,758 due to a heavier whole-life mix
  • − Adjusted EBITDA margin declined to 19% from 23% a year ago

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Strong Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 19.3 · elevated Equity put/call 0.63
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +40%
above
Price vs 50-day avg −12%
below
RSI (14) 39
neutral
MACD trend Negative
52-week position 68%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Strong
1-month return −11%
trailing
6-month return +72%
trailing
Relative strength +72%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $38 › 200d $24 — 50d above 200d
Institutional flow Accumulating
79 of 71 funds reported for Sep 30 · net +6.8M sh shares · +37 new
Insider flow Distributing
Net -$2.7M over 90 days · 100% sells
Short interest Falling
5.66% of shares out · ▼ -10.6% MoM · 2.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
71 holders — 13F breadth
Squeeze score 54
elevated · 0–100
Fundamentals
Excellent
Revenue growth +52%
Y/Y
EPS growth +44%
Y/Y
Free cash flow $34.7M
Buyback $100.0M
authorized
Quant / Vol
risk profile
Very High
Volatility 91%
annualized · 1-yr
Max drawdown −50%
past year
ATR 9.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 3 of last 3
Latest guidance · from the 8-K filed Nov 2, 2026
fourth quarter of 2026
Total Revenue $220M – $224M
prior qtr $235.22M midpoint −5.6% QoQ
Adjusted EBITDA Non-GAAP $30M – $32M
full fiscal year 2026
Total Revenue Raised $838M – $842M
Aug 3, 2026 $727M – $731M changed to Nov 2, 2026 $838M – $842M
prior FY $387.61M midpoint +116.7% Y/Y
Adjusted EBITDA Non-GAAP Raised $134M – $136M
Aug 3, 2026 $119M – $123M changed to Nov 2, 2026 $134M – $136M
Prior guidance period ended · from the Earnings Call filed Aug 3, 2026
Total revenue · third quarter of 2026 $160M – $164M
Adjusted EBITDA · third quarter of 2026 $23M – $25M
Guided vs delivered · last 3 settled
Total revenue third quarter of 2026
guided $160M – $164M
$235.22M Beat +45.2%
Total Revenue the second quarter of 2026
guided $114M – $118M
$189.56M Beat +63.4%
Total revenue first quarter of 2026
guided $144M – $146M
$193.1M Beat +33.2%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
2 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+40% Bullish
Price vs 50-day avg
−12% Bearish
RSI (14)
39 Neutral
MACD trend
Negative Bearish
52-week position
68% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $38 › 200d $24 — 50d above 200d
Institutional flow Accumulating
79 of 71 funds reported for Sep 30 · net +6.8M sh shares · +37 new
Insider flow Distributing
Net -$2.7M over 90 days · 100% sells
Short interest Falling
5.66% of shares out · ▼ -10.6% MoM · 2.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
71 holders — 13F breadth
Price context
position in its available closing range
Range low $10 Now $33 · 68% Range high $44
vs 200-day avg +40% vs 50-day avg -12%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Contribution margin non-GAAP 33% Three Months Ended June 30, 2026 filing —
Adjusted EBITDA non-GAAP $68.82M Six Months Ended June 30, 2026 —
Adjusted EBITDA margin non-GAAP 18% Six Months Ended June 30, 2026 —
Contribution profit non-GAAP $120.91M Six Months Ended June 30, 2026 —
Contribution profit margin non-GAAP 32% Six Months Ended June 30, 2026 —
New policies activated 107,847 Q2 2026 —
Non-GAAP net income non-GAAP $64.13M Six Months Ended June 30, 2026 —
Non-GAAP Net Income per Share: diluted non-GAAP $0.53 Q2 2026 —
Reported Average Revenue per Unit $1,758 Q2 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Insurance Brokers — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
LIFE
Ethos Technologies Inc.
this stock
$2.16B — +52.0% — 5.7%
MRSH
Marsh & Mclennan Companies, Inc.
$98.80B +12.0% +10.3% 24.9 1.3%
AJG
Arthur J. Gallagher & Co.
$72.55B +9.3% +10.1% 43.3 3.0%
AON
Aon plc
$71.77B -4.1% +7.7% 18.5 1.8%
WTW
Willis Towers Watson PLC
$30.92B +2.1% -2.2% 20.6 2.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
102
% held
37.5%
Reported
79 of 71
Top holder
SOFTBANK GROUP CORP.
Held Float
View
Held by Funds
Fund positions
30
View
Short & Settlement
Short Interest Falling
Shares short
3.7M
Days to cover
2.9d
Change
-435.1K sh
View
Short Volume
Short vol %
36%
As of
Nov 13, 2026
Short Total
View
Fails to Deliver
FTD shares
1.1K
Value
$39.4K
As of
Oct 8, 2026
View
Off-Exchange
Off-exchange %
57.7%
Week of
Oct 5, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$2.7M
Buyers / Sellers
0 / 3
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$387.6M
Net income (FY)
$71.2M
EPS diluted
$1.22
View
Buybacks
Authorized
$100.0M
View
Filings
SEC Filings
Latest
10-Q
Filed
Nov 4, 2026
This year
15
View
Proposed Sales
Value
$1.5M
Shares
40.0K
Filed
Oct 16, 2026
View
Exempt Offerings
Offering
$7.5M
Filed
Jan 24, 2022
View
Earnings & Events
Webcasts
Last webcast
Nov 2, 2026
View
Investor Relations
Latest news
Ethos Reports Third Quarter Fisca…
Published
Nov 2, 2026
View

Performance

5D 20D 120D MTD YTD
LIFE -0.8% -11.4% +72.3% -23.4% —
SPY +2.6% -1.2% +0.5% -0.2% +10.6%
vs SPY -3.3% -10.2% +71.8% -23.2% —

Capital returns

Buyback program · as of Aug 2, 2026
Authorized
$100.00M
Spent (derived)
—
Remaining
—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1788451 CUSIP 29765A101 13F (30d) 67 filings 67 filers Visit website Investor relations